Anika Therapeutics, Inc. Intangible Assets, Current
Anika Therapeutics, Inc. (ANIK) had Intangible Assets, Current of $1.70 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Goodwill and Other
us-gaap:IntangibleAssetsCurrent · last filed 2026-07-29
- 2026-06-30: Intangible Assets, Current $1.70M.
- 2026-03-31: Intangible Assets, Current $1.70M.
- 2025-12-31: Intangible Assets, Current $1.70M.
- 2025-03-31: Intangible Assets, Current $1.70M.
| Period end | Intangible Assets, Current |
|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $1.70M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.70M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $1.70M 10-Q · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |